Profile
Position
Alex Liu focuses on mergers and acquisitions, private equity investment & financing, and capital markets, with established expertise on takeover and restructuring of public companies, state-owned assets related transactions, cross-border M&A and red-chip restructuring.
In the field of merger and acquisitions, Alex has been involved in many representative deals, which include:
Takeover of control, such as,
- Infore Group’s over RMB 8.88 billion takeover of KUCA (603816.SH);
- Broadex’s (300548.SZ) takeover by YOFC (601869.SH; 06869.HK);
- Orient Zirconic’s (002167.SZ) takeover by LB Group (002601.SZ);
- Meiya Pico’s (300188.SZ) takeover by SDIC;
- Sichuan Shuangma’s (000935.SZ) takeover by IDG Capital; and
- Cangzhou Dahua’s (600230.SH) sale by a central SOE.
Restructuring by public companies, such as,
- Zoomlion’s (000157.SZ; 01157.HK) carve-out by way of RoadRover’s (002813.SZ) backdoor listing;
- Synermore Biologics’ sale to NUCIEN (688189.SH);
- NuClover’s sale to Jieqiang Equipment (300875.SZ);
- affiliates’ restructuring by SOE YNHC (001896.SZ); and
- merger of Huabei Expressway (000916) by China Merchants Highway.
Cross-border M&A transactions, such as,
- over RMB 3.3 billion strategic investment into CGN’s Brazilian subsidiary;
- over RMB 18.47 billion takeover of Israel’s ADAMA by Sanonda (000553.SZ);
- merger integration of Xiamen Port involving three A-shares and two HK listed companies;
- combination of CR Pharmaceutical and Beijing Pharmaceutical involving four A-shares companies;
- acquisition of Tianjin Port (600717.SH) by Tianjin Port Development (00382.HK) through shares exchange;
- RTO of HanKore Environment (U9E.SGX) by Everbright International (00257.HK);
- VSA injecting properties by CR Land (01109.HK);
- sale of TNUVA to Bright Food by APAX Fund; and
- acquisition of skiing resorts in Yabuli by Melco.
Red-chip or VIE restructuring, Alex’s representative clients include Xiyun, Douyu, EASOU Technology, Bangcle, Chunyu Yisheng, Baixing.com, and Baofeng Group etc.
In the field of PE investment and financing, Alex has represented numerous RMB or USD funds such as China Merchants Capital, CDB Capital, CIIF, Hony Capital, Goldstone, and Jinrong Street Capital etc., in investments ranging from technology, healthcare to energy sectors.
In capital markets, Alex has advised on the listings or additional issues on the stock exchanges in Shanghai, Shenzhen, Beijing, Hong Kong or US, including the IPO of China Resources Microelectronics (688396.SH) on SSE STAR, the first case in Chinese capital markets of an offshore red-chip company; Douyu.com (DOYU) and VisionChina (VISN)’s Nasdaq listing; Tong Ji Tang’s NYSE listing; Dynasty (00828), Huaying Highway (01823), Hongba Digital (00802) and Sanlin Global (019020)’s HKSE listing; Vanke’s B to H share conversion; and the delisting of Zhengzhou Gas, etc.
Career
2011 – present Global Law Office
2010 – 2011 Jones Day (Beijing)
2004 – 2009 Global Law Office
Languages
Education
2009 – 2010 UC Berkeley, LL.M.
2001 – 2004 Renmin University of China, LL.M.
1997 – 2001 Northeastern University, LL.B.
Content supplied by Global Law Office
Testimonials
Collated independently by Legal 500 research team.
‘All the lawyers are hands-on and easy to work with. They have the ability to explain in simple words complex matters and provide solutions.’
‘Roy Zhu is very professional and smart. What I specifically liked was that he handles complex matters in a way that really facilitates and solves the problem.’
'The M&A team led by Pengcheng Zhu of Global Law Firm focuses on providing full-cycle, multi-jurisdictional, and high-complexity M&A and restructuring solutions for multinational enterprises and investment institutions, especially in handling regulatory-sensitive transactions and cross-border investments in the Chinese market.’
'With his excellent professionalism and broad international vision, Pengcheng Zhu continues to provide clients with accurate, forward-looking and strategically valuable solutions in the complex and ever-changing legal environment of cross-border M&A. As a highly insightful communicator, Mr. Zhu is adept at quickly grasping the core and potential risks of transactions, and tailoring targeted and constructive trading strategies and execution plans based on a deep understanding of clients' business needs.'
'The team has extensive experience in the pharmaceutical sector and frequently provides clients with practical advice. Our team is familiar with new project approaches within the industry and offers flexible project recommendations.'
'They are also very familiar with new acquisition and merger methods in the industry and can provide clients with flexible project proposals that meet business needs.'
Key clients
- State Development & Investment Corp (SDIC) Luxshare Precision Industry Company Limited Infore Group China Merchants Group Jiangxi Copper China Life Asset Management Company China Film Co., Ltd. YOFC (Yangtze Optical Fibre and Cable Joint Stock Limited Company) Shanghai Foreign Service Group Co., Ltd. (FSG) Shudao Investment Group Co., Ltd. Luxshare Precision Limited Shenzhen SF Taisen Holdings (Group) Inc. Full-Life Technologies China Merchants Expressway Network & Technology Holdings Co., Ltd. Huaxia Financial Leasing Co., Ltd. GLP (Zhuhai) Equity Investment Management Co., Ltd. Shandong High-Speed Holdings Alphamab Oncology (9966.HK) Tianjin Pharmaceuticals Group Corporation Wanhua Chemistry

